verified SJR 0,374 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Springer New York

workspace_premium Q2 — Drug Discovery lock Subscription

Journal of Pharmaceutical Innovation

Journal of Pharmaceutical Innovation is a journal indexed in SJR in Drug Discovery and Pharmaceutical Science with an H index of 40. It has a price of 2690 €. It has an SJR impact factor of 0,374 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,374.

ISSN: 1872-5120

Publisher: Springer New York

Category: Drug Discovery

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,374 Q2

H-index 40

Acceptance rate pie_chart

35%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.690 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,374

H-index

Docs (year)

Docs 3y

368

Total refs

3846

Cites 3y

819

Citable 3y

357

Cites/Doc 2y

2.09

Ref/Doc

42.73

Immediate OA

2690 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Application of Bayesian Optimization for Pharmaceutical Product Development

Validation of Alternative Microbiological Method in Non-sterile Pharmaceutical Product Through the Reference Strains and Productive Environment Bioburden

Cetus 840¬Æ: A New Paradigm for a Modernized Fully Automated Dissolution System

Capitalizing on Aggregate Data for Gaining Process Understanding--Effect of Raw Material, Environmental and Process Conditions on the Dissolution Rate of a Sustained Release Product

Biogenesis of Gold Nanoparticles Using Plant Powders and Assessment of In Vitro Cytotoxicity in 3T3-L1 Cell Line

Bio-Pharma Science and Technology Finds a New Home on University Campuses

Best Practices for Drug Substance Stress and Stability Studies During Early-Stage Development Part I - Conducting Drug Substance Solid Stress to Support Phase Ia Clinical Trials

Balancing Risk and Costs to Optimize the Clinical Supply Chain - A Step Beyond Simulation

Author Correction: Enhanced Approaches to the Identification, Evaluation, and Control of Impurities

Attribute-Based Design Space: Materials-Science-Based Quality-By-Design for Operational Flexibility and Process Portability

Assistance for Predicting Deposition of Tranilast Dry Powder in Pulmonary Airways by Computational Fluid Dynamics

Assessment of Blend and Content Uniformity. Technical Discussion of Sampling Plans and Application of ASTM E2709/E2810

SHOW MORE ARTICLES

Application of Response Surface Methodology to Microwave-Assisted Extraction of Lysergol from Ipomoea Genus and Its Characterization by RP HPLC-UV

2-D Image Localization in Hyperspectral Image Analysis of Pharmaceutical Materials

Analytical Method Quality by Design for an On-Line Near-Infrared Method to Monitor Blend Potency and Uniformity

Analytical Method Development Using Transmission Raman Spectroscopy for Pharmaceutical Assays and Compliance with Regulatory Guidelines - Part II: Practical Implementation Considerations

An efficient method-development strategy for quantitative chemical imaging using terahertz pulse spectroscopy

Amorphization of Atorvastatin Calcium by Mechanical Process: Characterization and Stabilization Within Polymeric Matrix

Acoustic Testing and Characterization Techniques for Pharmaceutical Solid Dosage Forms

A Review on Solubility Enhancement of Carvedilol - a BCS Class II Drug

A Quantitative Method for Modeling Blend Composition Distributions in the Presence of Agglomerates

A New Rapid and Nondestructive Means for Determining the Moisture Content in Elastomer Closures used to Seal Lyophilized Products

A New Modeling Approach of Ultrasonic Extraction of Polyphenols from Carob

A Model-Based Methodology for Spray-Drying Process Development

FAQs

Journal of Pharmaceutical Innovation has an SJR of 0,374 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 2690 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Journal of Pharmaceutical Innovation is 35%.

Journal of Pharmaceutical Innovation

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Pharmaceutical Innovation?

What is the APC / publication cost?

What is the acceptance rate?